Electronic Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Implantable Drug Delivery Devices, Smart Metered Dose Inhalers), By Application (Diabetes, Oncology), By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Electronic Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
    • 3.2.1.2. Rising preference for home healthcare
    • 3.2.1.3. Integration of digital technologies and growing awareness of personalized medications
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced drug delivery devices
    • 3.2.2.2. Limited patient awareness and device-related complications
• 3.3. Key Technology Trends
• 3.4. Key Brands
• 3.5. Pipeline Analysis
• 3.6. Electronic Drug Delivery Devices Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's
    • 3.6.1.1. Bargaining power of suppliers
    • 3.6.1.2. Bargaining power of buyers
    • 3.6.1.3. Threat of substitutes
    • 3.6.1.4. Threat of new entrants
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTEL Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic landscape
    • 3.6.2.3. Social landscape
    • 3.6.2.4. Technological landscape
    • 3.6.2.5. Environmental landscape
    • 3.6.2.6. Legal landscape

Chapter 4. Electronic Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Electronic Drug Delivery Devices Market: Product Movement Analysis
• 4.3. Electronic Drug Delivery Devices Market by Product Outlook (Revenue, USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Smart Infusion Pumps (Infusion Systems)
  • 4.5.1. Smart Infusion Pumps (Infusion Systems) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.1. Non-biologic Smart Infusion Systems
      • 4.5.1.1.1. Non-biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.2. Biologic Smart Infusion Systems
      • 4.5.1.2.1. Biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
        • 4.5.1.2.1.1. Smart Infusion Insulin Pumps
          • 4.5.1.2.1.1.1. Smart Infusion Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
        • 4.5.1.2.1.2. Others
          • 4.5.1.2.1.2.1. Others Market Revenue Estimated and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.6. Smart Metered Dose Inhalers (Inhalation Devices)
  • 4.6.1. Smart Metered Dose Inhalers (Inhalation Devices) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.7. Implantable Drug Delivery Devices
  • 4.7.1. Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.7.1.1. Biologic Implantable Drug Delivery Devices
      • 4.7.1.1.1. Biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.7.1.2. Non-biologic Implantable Drug Delivery Devices
      • 4.7.1.2.1. Non-biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Electronic Drug Delivery Devices Market: Application Estimated & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Electronic Drug Delivery Devices Market: Application Movement Analysis
• 5.3. Electronic Drug Delivery Devices Market by Application Outlook (Revenue, USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Diabetes
  • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.6. Respiratory Diseases
  • 5.6.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.7. Oncology
  • 5.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.8. Cardiology
  • 5.8.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Electronic Drug Delivery Devices Market Movement Analysis
• 6.3. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Product
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.6. Europe
  • 6.6.1. Europe Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic plc
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Insulet Corporation
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Becton, Dickinson and Company
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Tandem Diabetes Care, Inc.
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Ypsomed AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Novo Nordisk A/S
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Sanofi S.A.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Eli, Lilly and Company
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. AstraZeneca plc
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. GlaxoSmithKline plc
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Boehringer Ingelheim International GmbH
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Pfizer, Inc.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. Teva Pharmaceutical Industries
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Phillips-Medisize, LLC
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives
  • 7.2.15. West Pharmaceutical Services, Inc.
    • 7.2.15.1. Company overview
    • 7.2.15.2. Financial performance
    • 7.2.15.3. Product benchmarking
    • 7.2.15.4. Strategic initiatives
  • 7.2.16. Gerresheimer AG
    • 7.2.16.1. Company Overview
    • 7.2.16.2. Financial performance
    • 7.2.16.3. Product benchmarking
    • 7.2.16.4. Strategic initiatives
  • 7.2.17. Nemera Group
    • 7.2.17.1. Company overview
    • 7.2.17.2. Financial performance
    • 7.2.17.3. Product benchmarking
    • 7.2.17.4. Strategic initiatives
  • 7.2.18. SHL Group
    • 7.2.18.1. Company overview
    • 7.2.18.2. Financial performance
    • 7.2.18.3. Product benchmarking
    • 7.2.18.4. Strategic initiatives
  • 7.2.19. Owen Mumford
    • 7.2.19.1. Company overview
    • 7.2.19.2. Financial performance
    • 7.2.19.3. Product benchmarking
    • 7.2.19.4. Strategic initiatives
  • 7.2.20. Haselmeier AG
    • 7.2.20.1. Company overview
    • 7.2.20.2. Financial performance
    • 7.2.20.3. Product benchmarking
    • 7.2.20.4. Strategic initiatives
  • 7.2.21. ICU Medical
    • 7.2.21.1. Company overview
    • 7.2.21.2. Financial performance
    • 7.2.21.3. Product benchmarking
    • 7.2.21.4. Strategic initiatives
  • 7.2.22. Hisamitsu Pharmaceutical Co., Inc.
    • 7.2.22.1. Company overview
    • 7.2.22.2. Financial performance
    • 7.2.22.3. Product benchmarking
    • 7.2.22.4. Strategic initiatives
  • 7.2.23. Sparsha Pharma International
    • 7.2.23.1. Company overview
    • 7.2.23.2. Financial performance
    • 7.2.23.3. Product benchmarking
    • 7.2.23.4. Strategic initiatives
  • 7.2.24. Baxter International, Inc.
    • 7.2.24.1. Company overview
    • 7.2.24.2. Financial performance
    • 7.2.24.3. Product benchmarking
    • 7.2.24.4. Strategic initiatives
  • 7.2.25. Fresenius Kabi AG
    • 7.2.25.1. Company overview
    • 7.2.25.2. Financial performance
    • 7.2.25.3. Product benchmarking
    • 7.2.25.4. Strategic initiatives
  • 7.2.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.2.26.1. Company overview
    • 7.2.26.2. Financial performance
    • 7.2.26.3. Product benchmarking
    • 7.2.26.4. Strategic initiatives
  • 7.2.27. Novartis AG
    • 7.2.27.1. Company overview
    • 7.2.27.2. Financial performance
    • 7.2.27.3. Product benchmarking
    • 7.2.27.4. Strategic initiatives
  • 7.2.28. AptarGroup, Inc.
    • 7.2.28.1. Company overview
    • 7.2.28.2. Financial performance
    • 7.2.28.3. Product benchmarking
    • 7.2.28.4. Strategic initiatives
  • 7.2.29. Teleflex Incorporates
    • 7.2.29.1. Company overview
    • 7.2.29.2. Financial performance
    • 7.2.29.3. Product benchmarking
    • 7.2.29.4. Strategic initiatives
  • 7.2.30. Abbott Laboratories
    • 7.2.30.1. Company overview
    • 7.2.30.2. Financial performance
    • 7.2.30.3. Product benchmarking
    • 7.2.30.4. Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 4 Global electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 5 North America electronic drug delivery devices market, by region, 2018 - 2030 (Revenue, USD Million)
• Table 6 North America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 7 North America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 8 U.S electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 9 U.S electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 10 Canada electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 11 Canada electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 12 Mexico electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 13 Mexico electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 14 Europe electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 15 Europe electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 16 Europe electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 17 UK electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 18 UK electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 19 Germany electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 20 Germany electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 21 France electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 22 France electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 23 Italy electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 24 Italy electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 25 Spain electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 26 Spain electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 27 Norway electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 28 Norway electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 29 Sweden electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 30 Sweden electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 31 Denmark electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 32 Denmark electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 33 Asia Pacific electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 34 Asia Pacific electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 35 Asia Pacific electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 36 Japan electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 37 Japan electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 38 China electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 39 China electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 40 India electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 41 India electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 42 Australia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 43 Australia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 44 South Korea electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 45 South Korea electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 46 Thailand electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 47 Thailand electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 48 Latin America electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 49 Latin America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 50 Latin America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 51 Brazil electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 52 Brazil electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 53 Argentina electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 54 Argentina electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 55 Middle East & Africa electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 56 Middle East & Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 57 Middle East & Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 58 South Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 59 South Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 60 Saudi Arabia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 61 Saudi Arabia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 62 UAE electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 63 UAE electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 64 Kuwait electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 65 Kuwait electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Electronic drug delivery devices market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis by Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Electronic drug delivery devices market, product outlook key takeaways (Revenue, USD Million)
• Fig. 12 Electronic drug delivery devices market: product movement analysis (Revenue, USD Million), 2023 & 2030
• Fig. 13 Smart infusion pumps (infusion systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 14 Non-biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 15 Biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 16 Smart infusion insulin pumps market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 18 Smart metered dose inhalers (inhalation devices) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 20 Biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 21 Non-biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 22 Smart transdermal patches (transdermal delivery systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 23 Others market revenue estimates and forecasts, 2018 -2030 (Revenue, USD Million)
• Fig. 24 Electronic drug delivery devices market, application outlook key takeaways (Revenue, USD Million)
• Fig. 25 Electronic drug delivery devices market: application movement analysis (Revenue, USD Million), 2023 & 2030
• Fig. 26 Diabetes market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 27 Respiratory Diseases market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 28 Oncology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 29 Cardiology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 30 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 31 Electronic drug delivery devices market: Regional key takeaways (Revenue, USD Million)
• Fig. 32 Electronic drug delivery devices market: regional outlook, 2023 & 2030, (Revenue, USD Million)
• Fig. 33 North America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 34 US electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 35 Canada electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 36 Mexico electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 37 Europe electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 38 UK electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 39 Germany electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 40 France electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 41 Spain electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 42 Italy electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 43 Sweden electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 44 Norway electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 45 Denmark electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 46 Asia Pacific electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 47 China electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 48 Japan electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 49 India electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million
• Fig. 50 South Korea electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 51 Australia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 52 Thailand electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 53 Latin America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 54 Brazil electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 55 Argentina electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 56 Middle East and Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 57 South Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 58 Saudi Arabia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 59 UAE electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 60 Kuwait electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 61 List of key emerging company's/technology disruptors/innovators